Functional	O
significance	O
of	O
VEGF	O
-	O
a	O
in	O
human	O
ovarian	B-Cancer
carcinoma	I-Cancer
:	O
role	O
in	O
vasculogenic	O
mimicry	O
.	O

Ovarian	B-Cancer
cancer	I-Cancer
is	O
a	O
silent	O
killer	O
,	O
and	O
shows	O
early	O
extensive	O
tumor	B-Cancer
invasion	O
and	O
peritoneal	B-Multi-tissue_structure
metastasis	O
.	O

The	O
microcirculation	O
of	O
most	O
tumors	B-Cancer
includes	O
cooperation	O
of	O
pre	O
-	O
existing	O
vessels	B-Multi-tissue_structure
,	O
intussusceptive	O
microvascular	B-Tissue
growth	O
,	O
postnatal	O
vasculogenesis	O
,	O
glomeruloid	B-Multi-tissue_structure
angiogenesis	O
and	O
vasculogenic	O
mimicry	O
(	O
VM	O
)	O
.	O

VM	O
is	O
critical	O
for	O
a	O
tumor	B-Cancer
blood	B-Organism_substance
supply	O
and	O
is	O
asscociated	O
with	O
aggressive	O
features	O
and	O
metastasis	O
.	O

Our	O
studies	O
highlight	O
the	O
plasticity	O
of	O
aggressive	O
human	O
ovarian	B-Cell
carcinoma	I-Cell
cells	I-Cell
and	O
call	O
into	O
question	O
the	O
underlying	O
significance	O
of	O
their	O
ability	O
to	O
form	O
VM	O
in	O
vitro	O
induced	O
by	O
VEGF	O
-	O
a	O
.	O

These	O
studies	O
also	O
show	O
their	O
clinicalpathological	O
features	O
of	O
the	O
cancers	B-Cancer
with	O
human	O
Paraffin	O
-	O
embedded	O
tumor	B-Tissue
tissue	I-Tissue
samples	I-Tissue
.	O

Results	O
show	O
that	O
the	O
process	O
:	O
VEGF	O
-	O
a	O
-	O
-	O
greater	O
than	O
EphA2	O
-	O
-	O
greater	O
than	O
MMPs	O
-	O
-	O
greater	O
than	O
VM	O
is	O
the	O
main	O
pathway	O
for	O
VM	O
formation	O
and	O
VEGF	O
-	O
a	O
appears	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
formation	O
of	O
VM	O
based	O
on	O
our	O
in	O
vitro	O
assays	O
and	O
clinical	O
immunohistochemical	O
analyses	O
.	O

VM	O
-	O
targeting	O
strategies	O
for	O
ovarian	B-Cancer
cancer	I-Cancer
include	O
anti	O
-	O
VEGF	O
-	O
a	O
treatment	O
,	O
knocking	O
down	O
the	O
EphA2	O
gene	O
and	O
using	O
antibodies	O
against	O
human	O
MMPs	O
if	O
the	O
tumor	B-Cancer
is	O
VM	O
positive	O
.	O

This	O
strategy	O
may	O
be	O
of	O
significant	O
value	O
in	O
laying	O
the	O
foundation	O
for	O
a	O
more	O
explicit	O
anti	O
-	O
tumor	B-Cancer
angiogenesis	O
therapy	O
.	O

